Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 5.49017 | 79 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 5.5467 | 79 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 5.63763 | 80 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 5.6783 | 79 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 5.68918 | 80 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 5.67676 | 82 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 5.77217 | 82 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 5.7274 | 81 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 5.87584 | 82 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 5.71143 | 80 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 5.68668 | 80 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 5.6892 | 80 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 5.70812 | 80 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 5.77375 | 81 |